MIRM

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Mirum Pharmaceuticals (MIRM) Earnings Date & Reports

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MIRM is expected to report earnings to fall 83.28% to -30 cents per share on May 01

Mirum Pharmaceuticals MIRM Stock Earnings Reports

Q1'25

Est.

$-0.31

Q4'24

Missed

by $1.55

Q3'24

Beat

by $0.15

Q2'24

Missed

by $0.05

Q1'24

Missed

by $0.12

The last earnings report on February 26 showed earnings per share of -185 cents, missing the estimate of -30 cents. With 881.08K shares outstanding, the current market capitalization sits at 2.03B.

View a ticker or compare two or three

Compare

MIRM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MIRM
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for MIRM (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

950 Tower Lane

Phone

+1 650 667-4085

Employees

264

Web

https://www.mirumpharma.com